The global urinary catheters market size was estimated at USD 6.17 billion in 2024 and is projected to reach USD 10.93 billion by 2033, growing at a CAGR of 6.6% from 2025 to 2033. The market’s growth is primarily driven by the rising prevalence of urological disorders, including urinary incontinence (UI), benign prostatic hyperplasia (BPH), and spinal cord injuries (SCI), all of which often require long-term catheterization for effective management.

The growing aging population, coupled with an increase in surgical procedures and hospitalizations, further contributes to the rising demand for urinary catheters. Additionally, the expanding adoption of home healthcare services and the growing preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials, enhance patient comfort and reduce infection risk, while greater awareness among patients and caregivers about available urinary management options also supports market expansion over the forecast period.

The burden of urological disorders continues to be a major driver. According to the National Center for Biotechnology Information (NCBI) in August 2024, approximately 13 million individuals in the U.S. are directly affected by urinary incontinence. Similarly, data from Continence Health Australia in March 2024 indicates that urinary incontinence affects up to 10% of Australian men and as many as 38% of Australian women. This significant and growing prevalence is fueling increased demand for urinary catheters, particularly external catheters, which are commonly used in the management of UI.

The rising prevalence of BPH is also expected to substantially boost demand for urinary catheters in the coming years. Catheters play a critical role in managing BPH symptoms by providing immediate relief from urinary retention and improving patients’ overall quality of life. For individuals with BPH, urinary catheters facilitate urine drainage by bypassing the obstruction caused by an enlarged prostate, making them an essential component of patient care. Given their importance in symptom management, the increasing incidence of BPH is projected to contribute to sustained growth in the urinary catheters market over the forecast period.

Key Market Trends & Insights:

• North America dominated the global urinary catheters market, holding the largest revenue share of 34.97% in 2024. The region’s leadership is driven by advanced healthcare infrastructure, high awareness of urological health, and the widespread availability of innovative catheter technologies.

• Within North America, the U.S. urinary catheters market accounted for the largest market revenue share of 82.27% in 2024, reflecting the country’s high prevalence of urological disorders, well-established healthcare facilities, and strong adoption of both hospital-based and home-care urinary management solutions.

• By product, the intermittent catheters segment led the market in 2024, holding the largest revenue share of 57.91%. The dominance of this segment is due to the growing preference for minimally invasive catheterization methods, which reduce infection risk, enhance patient comfort, and allow for periodic urinary drainage without long-term indwelling devices.

• By application, the urinary incontinence segment led the market in 2024, capturing the largest revenue share of 37.29%. This reflects the increasing prevalence of urinary incontinence across various age groups and the growing demand for specialized catheter solutions to manage the condition effectively.

• By type, the coated catheters segment held the largest revenue share of 61.06% in 2024. The popularity of coated catheters is driven by their ability to minimize friction during insertion, reduce infection risk, and improve patient comfort, making them the preferred choice for both hospital and home-care settings.

Order a free sample PDF of the Urinary Catheters Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 6.17 Billion

• 2033 Projected Market Size: USD 10.93 Billion

• CAGR (2025-2033): 6.6%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The urinary catheters industry is highly fragmented, consisting of both major global players and local market competitors. With existing market participants striving to capture a larger portion of the market, intense competition is expected, and the degree of competitiveness may continue to increase over time.

To maintain and strengthen their market positions, many companies are engaging in strategic initiatives, including new product launches, mergers and acquisitions, and geographic expansion. These efforts aim to enhance product portfolios, broaden market reach, and gain a competitive advantage over rival firms.

Consequently, as these diverse strategies are implemented by market players, the urinary catheters industry is expected to experience steady growth throughout the forecast period, driven by innovation, increasing adoption of advanced products, and rising demand from both hospital and home-care settings.

Key Players

• BD

• Coloplast Corp

• B.Braun SE

• Medline Industries, LP.

• Hollister Incorporated

• Cook

• Teleflex Incorporated

• Optimum Medical Limited

• Convatec

• Boston Scientific Corporation

• Ur24Technology, Inc.

• Stryker

• InnoCare Urologics

• Boehringer Laboratories, LLC

• Consure Medical

• TillaCare Ltd.

• Medtronic

• Urotronic, Inc. (Laborie)

• Silq Technologies

• Wellspect HealthCare, a Dentsply Sirona Company

• GHC German Health Care GmbH

• Sterimed Group

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The urinary catheters market is projected to grow significantly over the coming years, driven by rising prevalence of urological disorders (such as urinary incontinence and benign prostatic hyperplasia), aging populations, and increasing demand for both hospital-based and home healthcare urinary management solutions. Advancements in catheter technology — including coated, antimicrobial, and patient friendly designs — along with greater awareness of non invasive catheterization options are supporting wider adoption. The market’s growth is further fueled by the shift toward intermittent and external catheters, reflecting a broader trend toward comfort, safety, and convenience in urinary care.